In vivo, asparagine deamidation has been reported in pathological conditions associated with oxidative stress as for example for Tau protein and β-amyloid peptides in Alzheimer's disease [22–25]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.